Eureka Prize goes to hepatitis B cure

Eureka Prize goes to hepatitis B cure.
Eureka Prize goes to hepatitis B cure. | Courtesy of
A team from the Walter and Eliza Hall Institute has earned the 2015 Australian Museum Eureka Prize for Infectious Disease Research for their search for a hepatitis B cure.

The winners include: Dr. Cody Allison; Dr. Marc Pellegrini, lead clinician-scientist; Mr. Michael Stutz; Mr. James Cooney; Mr. Simon Preston; Mr. Jesse Toe; and Dr. Greg Ebert, the winner of the 2014 Bupa Health Foundation Emerging Health Researcher Award.

“Our team is dedicated to tackling some of the biggest challenges in infectious disease,” Pellegrini said. “Chronic infectious diseases including HIV, hepatitis and tuberculosis are an enormous burden to humanity, particularly in the developing world. Our work really takes a new approach in how we hope to treat – and potentially cure – these diseases.”

The team’s promising new treatment combines antiviral therapies with an anticancer drug. The results from the preclinical models show that it is 100-percent effective at eradicating hepatitis B infections.

“Despite the availability of new medicines, it became clear that the virus could be stalled but that we couldn’t cure people at all,” Pellegrini said. “It made me interested in finding cures for all these infections for which we have medicines to control, but not cure the disease.”

Further details are available in the Proceedings of the National Academy of Sciences journal.

Organizations in this Story

Bupa Health Foundation National Academy of Sciences Walter and Eliza Hall Institute

Want to get notified whenever we write about any of these organizations ?
Next time we write about any of these organizations, we'll email you a link to the story. You may edit your settings or unsubscribe at any time.